Effect of lisuride and LSD on monoamine synthesis after axotomy or reserpine treatment in rat brain.
D006916:5-Hydroxytryptophan / Q000096:biosynthesis / Q000378:metabolism; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001369:Axons / Q000502:physiology*; D001679:Biogenic Amines / Q000096:biosynthesis*; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000096:biosynthesis / Q000378:metabolism; D004873:Ergolines / Q000494:pharmacology*; D006220:Haloperidol / Q000494:pharmacology; D006900:Hydroxylation; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D051381:Rats; D012110:Reserpine / Q000494:pharmacology*; D014364:Tryptophan / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism; D014508:Urea / Q000031:analogs & derivatives / Q000494:pharmacology
D001679:Biogenic Amines; D004873:Ergolines; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D014364:Tryptophan; D008238:Lysergic Acid Diethylamide; D014508:Urea; D006916:5-Hydroxytryptophan; D006220:Haloperidol; D001058:Apomorphine